CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- 8-K Event Executive or director change
- 4 Conversion See Remarks acquired 926,539 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 19,153 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 34,711 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy 10% owner bought 600,000 shares at $16.00 ($9,600,000)
- 4 Conversion Director acquired 23,917 shares (conversion)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 1,563 shares at $16.00 ($25,008)
- 4 Conversion Director acquired 715,653 shares (conversion)
- 4 Open-market buy CHIEF MEDICAL OFFICER bought 17,000 shares at $16.00 ($272,000)
- 4 Open-market buy PRESIDENT AND CEO bought 3,125 shares at $16.00 ($50,000)
- 4 Conversion Director acquired 47,709 shares (conversion)
- SC 13G Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Bylaws or fiscal year change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 8 of 10 · 198 filings